233 related articles for article (PubMed ID: 2970367)
1. A study of adrenal corticol function and its reserve activity in long-acting injectable contraceptive users.
Amatayakul K; Petpoo W; Ratanawananukul N; Tanthayaphinant O; Tovanabutra S; Suriyanon V
Contraception; 1988 May; 37(5):483-92. PubMed ID: 2970367
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile.
Fahmy K; Abdel-Razik M; Shaaraway M; al-Kholy G; Saad S; Wagdi A; al-Azzony M
Contraception; 1991 Oct; 44(4):419-30. PubMed ID: 1836754
[TBL] [Abstract][Full Text] [Related]
3. The effects of long-acting injectable contraceptives on carbohydrate metabolism.
Amatayakul K; Suriyanon V
Int J Gynaecol Obstet; 1985 Oct; 23(5):361-8. PubMed ID: 2866986
[TBL] [Abstract][Full Text] [Related]
4. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
[TBL] [Abstract][Full Text] [Related]
5. Long-acting hormonal contraceptives for women.
Garza-Flores J; Hall PE; Perez-Palacios G
J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
[TBL] [Abstract][Full Text] [Related]
6. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report.
Contraception; 1983 Jul; 28(1):1-20. PubMed ID: 6226488
[TBL] [Abstract][Full Text] [Related]
7. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
[TBL] [Abstract][Full Text] [Related]
8. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
Swenson I; Khan AR; Jahan FA
Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
[TBL] [Abstract][Full Text] [Related]
9. Acceptability of injectable contraceptives in Assiut, Egypt.
Salem HT; Salah M; Aly MY; Thabet AI; Shaaban MM; Fathalla MF
Contraception; 1988 Dec; 38(6):697-710. PubMed ID: 2975583
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
Sang GW
Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters.
Haiba NA; el-Habashy MA; Said SA; Darwish EA; Abdel-Sayed WS; Nayel SE
Contraception; 1989 Jun; 39(6):619-32. PubMed ID: 2666019
[TBL] [Abstract][Full Text] [Related]
12. Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives. From the World Health Organization Special Programme for Research, Development, and Research Training in Human Reproduction; Task Force on Long-acting Systemic Agents for the Regulation of Fertility.
Gray RH; Parker RA; Diethelm P
Br J Obstet Gynaecol; 1981 Mar; 88(3):317-21. PubMed ID: 7008825
[TBL] [Abstract][Full Text] [Related]
13. Serium protein-bound carbohydrate and seromucoid levels during long-acting progestational contraceptive therapy.
Saleh FM
Contraception; 1977 Oct; 16(4):399-407. PubMed ID: 923250
[TBL] [Abstract][Full Text] [Related]
14. A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
Bassol S; Hernandez C; Nava MP; Trujillo AM; Luz de la Cruz D
Contraception; 1995 May; 51(5):307-11. PubMed ID: 7628206
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-progestogen once-a-month injectable contraceptives and serum prolactin.
Garza-Flores J; Alba VM; Cravioto MC; Hernandez L; Perez-Palacios G; Alvarado G; Rivera R; Recio R; Bassol S
Contraception; 1989 May; 39(5):519-29. PubMed ID: 2524362
[TBL] [Abstract][Full Text] [Related]
16. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
[TBL] [Abstract][Full Text] [Related]
17. Return of fertility in women discontinuing injectable contraceptives.
Fotherby K; Howard G
J Obstet Gynaecol (Lahore); 1986 Apr; 6 Suppl 2():S110-5. PubMed ID: 12315276
[TBL] [Abstract][Full Text] [Related]
18. Pituitary response to LHRH in long-term users of injectable contraceptives.
Ismail AA; el-Faras A; Rocca M; el-Sibai FA; Toppozada M
Contraception; 1987 May; 35(5):487-95. PubMed ID: 2957167
[TBL] [Abstract][Full Text] [Related]
19. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: noresthisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects.
Contraception; 1978 May; 17(5):395-406. PubMed ID: 657807
[TBL] [Abstract][Full Text] [Related]
20. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives.
Fraser IS
Contraception; 1983 Oct; 28(4):385-97. PubMed ID: 6230212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
